You are viewing an old version of this page. View the current version.
Compare with Current
View Page History
« Previous
Version 2
Next »
Discussion items
Item | Description | Mins | Owner | Notes & Actions |
---|
1 | Opening | 5 | | Welcome & Notification of Recording |
2 | Substances Co-ordination | 10 | | Updates on Substances Co-Ordination: - Step 1: Substances in multiple extensions
- Step 2: Substances in one extension
- Country self-review/first pass
- Then, SI will review in scope
|
3 | Hydration - Demonstrate Examples | 35 | Yongsheng Gao | Updates on development work in relation to hydration substances. |
4 | Vaccine Substances | 5 | Shane Byrnes | WHO recommended flu vaccine antigen substances for 2025/2026 season (Northern Hemisphere) are now available in International Release |
5 | AOB | 5 | All |
|
6 | Topic Backlog |
|
| - Hydration Subsumption
- Less Granular Clinical Drug
- Elemental Substances (Matt, AUS)
- Substances Co-ordination
- Step 1: Substances in multiple extensions
- Step 2: Substances in one extension
- Step 3: Ongoing Substance Co-ordination (capturing at regulator level)
- Medication Stopped v Medication Discontinued (Karen, SI)
- Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work + ES)
- Value range of a |Has container type| attribute (Linda, CA)
- Top level children of 373873005 |Pharmaceutical / biologic product| hierarchy - are members using/how are members using? (AUS)
Group Input on Patch Strength RepresentationDose Form Intended Site v Route of Administration (BEL)Drug extension MRCM attributes (CA, AUS)
|
No files shared here yet.